Profile data is unavailable for this security.
About the company
Jinyao Pharmaceutical Co Ltd, formerly Tianjin Tianyao Pharmaceuticals Co., Ltd., is a China-based company mainly engaged in the research and development, production and sales of corticosteroids and amino acid APIs and preparations. The Company's main products include dexamethasone series, prednisone series, methylprednisolone series, betamethasone series and more than 40 varieties of corticosteroid raw materials, 23 varieties of amino acid raw materials, and 16 dosage forms such as tablets, injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, and inhalation preparations. The Company mainly operates in the domestic market and overseas markets.
- Revenue in CNY (TTM)3.78bn
- Net income in CNY117.05m
- Incorporated1999
- Employees2.68k
- LocationJinyao Pharmaceutical Co LtdNo. 221, Huanghai Road, Development ZoneTIANJIN 300457ChinaCHN
- Phone+86 2 260740048
- Fax+86 2 265277561
- Websitehttp://www.tjpcty.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Bioperfectus Technologies Co Ltd | 1.52bn | 27.53m | 3.90bn | 1.08k | 141.67 | 1.08 | -- | 2.57 | 0.4697 | 0.4697 | 25.89 | 61.46 | 0.3397 | 1.89 | 3.36 | 1,402,711.00 | 0.6161 | 40.17 | 0.7358 | 50.42 | 59.64 | 64.77 | 1.81 | 37.51 | 5.70 | -- | 0.0851 | 27.19 | 94.95 | 96.84 | 53.19 | 112.02 | 64.29 | -- |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.39bn | -56.07m | 3.93bn | 1.84k | -- | 2.23 | -- | 1.65 | -0.1295 | -0.1295 | 6.73 | 5.13 | 0.4332 | 2.02 | 6.03 | 1,294,824.00 | -1.12 | 4.05 | -2.30 | 6.93 | 22.42 | 35.90 | -2.58 | 10.26 | 0.4665 | 0.557 | 0.6553 | 54.38 | 6.57 | 24.55 | -123.43 | -- | 39.12 | 1.88 |
| Jinyao Pharmaceutical Co Ltd | 3.78bn | 117.05m | 4.09bn | 2.68k | 34.89 | 1.38 | -- | 1.08 | 0.1072 | 0.1072 | 3.46 | 2.71 | 0.5914 | 2.20 | 9.80 | 1,412,557.00 | 2.54 | 1.91 | 4.65 | 3.40 | 45.14 | 46.33 | 4.30 | 3.31 | 0.7125 | 10.20 | 0.2382 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
| Assure Tech Hangzhou Co Ltd | 355.41m | 99.34m | 4.20bn | 950.00 | 42.23 | 0.8139 | -- | 11.81 | 0.7819 | 0.7819 | 2.80 | 40.57 | 0.0527 | 0.7442 | 1.83 | 374,116.00 | 1.46 | -- | 1.81 | -- | 31.02 | -- | 27.80 | -- | 8.23 | -- | 0.0195 | -- | 287.97 | -- | 312.26 | -- | -- | -- |
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 222.11m | 4.23bn | 1.16k | 19.03 | 2.37 | -- | 2.92 | 2.37 | 2.37 | 15.44 | 19.01 | 0.6713 | 1.50 | 8.93 | 1,246,491.00 | 9.31 | 11.21 | 11.21 | 14.05 | 64.09 | 69.00 | 13.88 | 13.96 | 3.02 | -- | 0.0252 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 845.14m | 230.48m | 4.37bn | 1.02k | 18.75 | 2.38 | -- | 5.17 | 1.23 | 1.23 | 4.52 | 9.72 | 0.4223 | 3.00 | 5.22 | 831,826.60 | 11.50 | 10.33 | 12.71 | 11.26 | 87.58 | 88.06 | 27.23 | 22.05 | 5.80 | -- | 0.0002 | 36.85 | 28.46 | 7.68 | 34.61 | 14.81 | 73.20 | -- |
| Shanghai Medicilon Inc | 1.60bn | 175.05m | 4.38bn | 3.11k | 22.80 | 1.64 | -- | 2.73 | 1.43 | 1.43 | 13.21 | 19.85 | 0.5606 | 5.72 | 2.39 | 485,695.90 | 6.13 | 14.50 | 7.89 | 17.97 | 31.26 | 41.25 | 10.93 | 20.81 | 2.67 | 38.48 | 0.1543 | 18.02 | 42.12 | 46.09 | 19.85 | 52.05 | 46.98 | -- |
Data as of Apr 23 2024. Currency figures normalised to Jinyao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cinda Fund Management Co. Ltd.as of 30 Jun 2023 | 11.39m | 1.04% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 9.60m | 0.88% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 6.69m | 0.61% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2023 | 4.57m | 0.42% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.79m | 0.16% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 1.69m | 0.16% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2023 | 1.40m | 0.13% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2023 | 1.12m | 0.10% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 391.10k | 0.04% |
| China Fund Management Co., Ltd.as of 30 Jun 2023 | 344.90k | 0.03% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
